The Role of Apparent Diffusion Coefficient Quantification in Differentiating Benign and Malignant Renal Masses by 3 Tesla Magnetic Resonance Imaging

被引:10
|
作者
Goya, Cemil [1 ]
Hamidi, Cihad [1 ]
Bozkurt, Yasar [2 ]
Yavuz, Alpaslan [3 ]
Kuday, Suzan [4 ]
Gumus, Hatice [1 ]
Turkcu, Gul [5 ]
Hattapoglu, Salih [1 ]
Bilici, Aslan [1 ]
机构
[1] Dicle Univ, Fac Med, Dept Radiol, Diyarbakir, Turkey
[2] Dicle Univ, Fac Med, Dept Urol, Diyarbakir, Turkey
[3] Yuzuncu Yil Univ, Fac Med, Dept Radiol, Van, Turkey
[4] Bismil State Hosp, Dept Radiol, Diyarbakir, Turkey
[5] Dicle Univ, Fac Med, Dept Pathol, Diyarbakir, Turkey
关键词
Apparent diffusion coefficient; diffusion-weighted magnetic resonance imaging; renal neoplasms; 3 T MRI; WEIGHTED MRI; ADC MEASUREMENT; LESIONS; UTILITY; STROKE; EXPERIENCE; VALUES;
D O I
10.5152/balkanmedj.2015.15475
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Diffusion-weighted magnetic resonance imaging (DWI) is a widely-accepted diagnostic modality whose efficacy has been investigated by numerous past studies in the differentiation of malignant lesions from benign entities. Aims: The aim of this study was to evaluate the efficiency of diffusion-weighted magnetic resonance imaging in the characterization of renal lesions. Study Design: Diagnostic accuracy study. Methods: A total of 137 patients with renal lesions were included in this study. The median apparent diffusion coefficient (ADC) values as well as the b 800 and b 1600 signal intensities of normal kidneys, solid components of mixed renal masses, and total cystic lesions were evaluated. Results: There were significant differences between the ADC values of lesions and normal renal parenchyma, and between the ADC values of benign and malignant renal lesions on DWIs at b values of 800 and 1600 s/mm(2) (p<0.001 and p<0.001, respectively). There were significant differences between the ADC values of Bosniak Category 1 and 2 cysts and the ADC values of Bosniak Category 1 and 3 cysts on DWIs at b values of 800 s/mm(2) (p<0.001) and 1600 s/mm(2) (p<0.001). A cutoff value of 1.902 x 10(-3) mm(2)/s for the ADC with a b value of 800 s/mm(2) provided 88% sensitivity and 96% specificity for differentiation between benign and malignant renal lesions. A cutoff value of 1.623 x 10(-3) mm(2)/s for the ADC with a b value of 1600 s/mm(2) provided 79% sensitivity and 96% specificity (p<0.001) for the differentiation between benign and malignant renal lesions. Conclusion: Accurate assessment of renal masses is important for determining the necessity for surgical intervention. DWI provides additional value by differentiating benign from malignant renal tumors and can be added to routine kidney MRI protocols.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 50 条
  • [31] How to Discriminate Lung Cancer From Benign Pulmonary Nodules and Masses? Usefulness of Diffusion-Weighted Magnetic Resonance Imaging With Apparent Diffusion Coefficient and Inside/Wall Apparent Diffusion Coefficient Ratio
    Usuda, Katsuo
    Iwai, Shun
    Yamagata, Aika
    Iijima, Yoshihito
    Motono, Nozomu
    Doai, Mariko
    Matoba, Munetaka
    Hirata, Keiya
    Uramoto, Hidetaka
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021, 15
  • [32] Role of MRI Apparent Diffusion Coefficient (ADC) Quantification in the differentiation between benign and malignant pulmonary lesions
    Hussein, Khaled
    Eldin, Marwan Nasr
    Mostafa, Hisham
    Hamed, Ahmed
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [33] Value of apparent diffusion coefficient measurement for discrimination of focal benign and malignant hepatic masses
    Kilickesmez, O.
    Bayramoglu, S.
    Inci, E.
    Cimilli, T.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2009, 53 (01) : 50 - 55
  • [34] DIFFERENTIATION BETWEEN BENIGN AND MALIGNANT THYROID NODULE WITH DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING AND APPARENT DIFFUSION COEFFICIENT MEASUREMENTS AND ITS HISTOPATHOLOGICAL CORRELATION
    Noufal, P. M.
    Ramakrishnan, K. G.
    Kurup, Shailage
    Ali, Naseer
    Janardhanan, Sujith
    Rabia, Tajmal Aboo
    Unni, Vipin
    Bernaitis, L.
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (07): : 843 - 849
  • [35] Magnetic Resonance Imaging of the Pediatric Kidney Benign and Malignant Masses
    Gee, Michael S.
    Bittman, Mark
    Epelman, Monica
    Vargas, Sara O.
    Lee, Edward Y.
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2013, 21 (04) : 697 - +
  • [36] Magnetic Resonance Imaging of the Pediatric Liver Benign and Malignant Masses
    Keup, Christopher P.
    Ratnaraj, Felicia
    Chopra, Pooja R.
    Lawrence, Charles A.
    Lowe, Lisa H.
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2013, 21 (04) : 645 - +
  • [37] Role of Diffusion-Weighted Magnetic Resonance Imaging in Differentiating Benign From Malignant Thyroid Lesions: A Prospective Study
    Bhargava, Kanika
    Narula, Harneet
    Mittal, Amit
    Sharma, Divya
    Goel, Kritesh
    Nijhawan, Divya
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (04) : TC1 - TC4
  • [38] Apparent diffusion coefficient and vascular signal fraction measurements with magnetic resonance imaging: feasibility in metastatic ovarian cancer at 3 Tesla
    Sala, Evis
    Priest, Andrew N.
    Kataoka, Masako
    Graves, Martin J.
    McLean, Mary A.
    Joubert, Ilse
    Griffiths, John R.
    Crawford, Robin A. F.
    Jimenez-Linan, Mercedes
    Earl, Helena M.
    Brenton, James D.
    Lomas, David J.
    EUROPEAN RADIOLOGY, 2010, 20 (02) : 491 - 496
  • [39] Magnetic resonance imaging: value of diffusion-weighted imaging in differentiating benign from malignant breast lesions
    Stijven, Sandra
    Gielen, Ellen
    Bevernage, Charlotte
    Horvath, Monique
    Meylaerts, Liesbeth
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 166 (02) : 215 - 220
  • [40] The Diagnostic Performance of Maximum Uptake Value and Apparent Diffusion Coefficient in Differentiating Benign and Malignant Ovarian or Adnexal Masses: A Meta-Analysis
    Hu, Xianwen
    Liang, Zhigang
    Zhang, Chuanqin
    Wang, Guanlian
    Cai, Jiong
    Wang, Pan
    FRONTIERS IN ONCOLOGY, 2022, 12